Home HIV testing likely by year-end in US
This article was originally published in Clinica
Johnson & Johnson's home-collection HIV test could be approved by the end of the year. As long as the test fulfils safety and effectiveness criteria there is no longer a policy impediment to home testing, says the FDA.
You may also be interested in...
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.
The COVID-19 pandemic has triggered extraordinary levels of collaboration. But competition remains, and many newly created coalitions have yet to be stress tested.